[ RadSafe ] Your letter of Jan. 6
Andree Desiree Wilson and Richard Wilson
wilson5 at fas.harvard.edu
Thu Jan 19 10:31:01 CST 2006
In this connection my paper on arsenic risk may be of
interest.
<http://phys4.harvard.edu/%7Ewilson/publications/ppaper807.html>"Underestimating
Arsenic's Risk" Regulation 24(3) pp50-53
Dick Wilson
May 11th 2001
Introduction.
The proposal by the US EPA in the year 2000 to reduce the allowable
level of arsenic in drinking water was the first major decision of
the EPA under the regulations which allow the use of Cost-Benefit
analysis to make a decision. Therefore the way in which the EPA
make this decision is of extreme importance. Moreover as I will
explain below, the effect of Chronic Arsenic poisoning throughout the
world is a major one and the decision is therefore a very important
one in its own right.
The paper by Burnett and Hahn must be considered as one of many ways
in which the problem can be discussed. They have several points of
disagreement with the way in which the problem was discussed by both
NAS and EPA. In this note I discuss each of these disagreements and
point out that some, if accepted would involve major changes in
practices used by the EPA and generally accepted by the American
people, and some others are more controversial that Burnett and Hahn imply.
The arsenic problem
Arsenic has been used in commerce for thousands of years. Recently
it has been used in non-ferrous metals processing, it has been
sprayed on vineyards and other crops as arsenical pesticides before
the more effective chlorinated hydrocarbons were discovered. It has
been used in medicine: taken for a limited time at high doses, just
below the acute toxic threshold, it cures leukemia. It was used
a cure for syphilis before the superior sulphur drugs and penicillin
were discovered. In dilute solution it was as an over-the-counter
cure (Fowler's solution) for mild ailments.
Arsenic has long been known to be acutely poisonous at high
doses. It possessed a peculiarity: in an individual, taking doses
just sub acute raises the acute toxic level. This makes it the
darling of detective story writers. A villain can take subacute
doses for a week, and then share a meal containing toxic arsenic
doses with his victim. It is recorded that the Borgias used this
method. But for many years it was thought that at lower doses no
adverse effects were seen. A few cancers were found in small groups
of people: Skin cancers from excessive medical use of arsenic (using
Fowler's solution regularly over a long time) were described by
Hutchinson in 1888. Lung cancers from arsenic inhaled arsenical
pesticides were found in the 1890s and from smelters in the 1920s. A
rare liver cancer, angiosarcoma, can be caused by arsenic as easily
as it can be caused by vinyl chloride. But these were
discounted, and a threshold was assumed below which no cancers will be seen.
This view, that Chronic Health effects do not occur with ordinary
uses of arsenic was reinforced by the standard toxicological
predictions. For a century public health has been considerably
improved by tests of materials in animals before using them where
humans can be exposed. A chemical that is toxic to rats and mice is
toxic in people. Moreover the relation is quantitative. When the
same fraction of the chemical is included in the human diet as the
animal diet, the toxic effect is about the same and the probability
of developing cancer is about the same. Animals, particularly
rats and mice, did not develop cancer from arsenic. Ergo, people
don't develop cancers . That animals do not develop cancer led
toxicologists and almost everyone else, including myself, to believe
that the limited data on humans was consistent with the idea that
people who ingest moderate doses of arsenic do not develop
cancer. But in a paper which shocked everyone, C.J. Chen and
collaborators from Taiwan described cancers of the bladder, kidney
and lung attributable to ingested arsenic. This was confirmed by
scientists from Argentine and Chile and by Dr Lu and collaborators
from Inner Mongolia. It is apparent that, contrary to the previous
belief of most scientists, animal data up to that time were bad
predictors of arsenic related human cancers. This may be changing
somewhat. In a recent study Dr Ng of Brisbane, Australia persuaded
mice to develop cancer at small doses of arsenic. Moreover a
metabolite of arsenic, Di Methyl Acetyl Arsenic or DMAA,
causes cancer - apparently both as a promoter and as an initiator.
The number of people in the world affected by arsenic is large. The
N.Y. Times on April 7th 2001 referred to a small study in Chile. In
that "small" study cohort, 500 people got cancer in excess of the
background, a larger number than the 450 more than background that
developed cancer from the atomic bomb explosions in Hiroshima and
Nagasaki. In Bangladesh 30 million people are exposed to arsenic at
levels higher than EPA presently permit (>50 ppb in the water). I
have been quoted many times, without ever being contested, that the
Bangladesh catastrophe makes Chernobyl look like a Sunday School
picnic. Some thousands have already died from secondary effects of
the skin lesions and there are estimates by responsible that a
million people will die eventually. The crucial question is : "What
does that imply for Americans exposed to arsenic at present
levels? As often happens the whole world is watching us as we
discuss what to do.
About 10% of Chileans or Taiwanese who drank water containing 500 ppb
of arsenic developed cancer - mostly lung cancer. A fundamental
issue is how one estimates a risk at lower levels from the generally
accepted measurements at higher exposure levels. On this issue
there is a strong disagreement so that it is important to understand
the two extreme positions. On the one hand there are scientists and
physicians who think that linear dose-response is most likely, and on
the other hand, some scientists believe that there exists a
threshold below which no effect will be seen. This disagreement
permeates all studies of environmental cancer risk. 50 years
ago, Sir Richard Doll and Dr Armitage discussed a mult-stage theory
of cancer, and how the theory might describe both naturally occurring
cancers and cancers caused by an external agent. They noted that
most cancers caused by an external agent cannot be distinguished from
those that occur naturally and may be fundamentally
indistinguishable. It was then reasonable to assume that the
external agent affected one stage in the cancer development in the
same way as the natural processes do. 25 years ago a group of
scientists including one of Doll's collaborators, Sir Richard
Peto, pointed out that the argument is very general. If an agent
increases the probability of any step in the cancer formation process
in the same way as natural processes, then almost any
biological dose-response relationship becomes linear at low
doses. This formed the basis for the EPA assumption of low dose
linearity as a default for all carcinogens. It is the default
linearity argument that I described in the pages of Regulation 18
months ago. If one uses the default dose-response and starts from
the data from Taiwan or Chile where there is a risk of 10% (mostly a
lung cancer risk) for people who drink water containing 500 ppb of
arsenic, the default assumption leads to the 1% risk at presently
allowable levels, 50 ppb, that NAS in 1999 reported as
possible. This is a higher risk than Burnett and Hahn take as an
upper limit. Moreover it is highly probable, as Burnett and Hahn
point out, that there are other cancers and other chronic effects due
to arsenic. While it is becoming popular to attribute any
unexplained ailment to such exposures as arsenic in the cured wood in
one's fence, some of these attributions are probably correct. A
doubling - or even quadrupling - of the 1% figure may not then be unreasonable.
Some toxicologists have suggested that the dose of arsenic to the
relevant organ does not increase linearly with ingested dose. This
remains unproven and is certainly not a general situation for
carcinogens. For many carcinogens, the number of DNA adducts is
almost proportional to ingested dose over 5 orders of magnitude -
showing unequivocally that the pollutant in question reached the cell
- even when some toxicologists were arguing that it does not. We
are even unsure of the relevant organ for the induction of internal
cancers. We think we understand why an inhaled material can cause
havoc in the lung. But how does ingestion of arsenic produce lung
cancer? Even after the Taiwan data were generally accepted, this part
was questioned because it seemed so unlikely that ingested material
would affect the lung in an important way. But the data from Chile
seem unequivocal. Some biologists and toxicologists insist on their
belief that there is a threshold below which there is no effect, or
at least non linearity. Even worse than the fact that we were told,
until recently, that arsenic does not cause cancer in animals and
therefore is unlikely to cause cancer in people, is the fact
that recent studies show that a metabolite of arsenic,
DiMethylArsenic Acid (DMAA) does cause bladder cancer in
rodents. Therefore it eems to me that if these toxicologists and
biologists base their conclusion upon animal data, they have the
burden of explaining why they were wrong for nearly a
century. Indeed between the major arsenic conferences of the
Society for Environmental Geochemistry and Health (SEGH) in San
Diego in 1997 and 2000 there seemed to me to be a change in attitude
of most particpants - they no longer believed that animal toxicology
was useful for the present discussion.
How one addresses the two approaches to discussing risks at low dose,
the macro approach of default linarity and the microapproach of the
toxicologist is a core problem that underlies all EPA
regulations. I would like to see NAS and EPA study should address
the default linearity approach and the difference from the
toxicological approach, and do so in all generality so that we may
learn from the behavior of other agents and substances, and also
learn how to apply the insights gained for the future. Meanwhile
Burnett and Hahn take a probability distribution of health
effects. I would take a bimodal distribution corresponding to the
difference in perspective, which changes with time even in the
absence of new data.
Does one, and should one discount lives lost in the future?
Burnett and Hahn argue, as Raiffa and Weinstein did in a seminal
paper that one should discount lives saved in the future with the
same discount rate as used in direct economic analyses. Others have
disagreed. But it is abundantly clear that American society as a
whole has not agreed with discounting. With a 7% discount rate on
lives lost in the future, little money should be spent on waste
disposal. Indeed with even a 0.1% discount rate, the US is clearly
spending much too much on consideration of disposal of high level
nuclear waste. To choose to discount lives is therefore a policy
decision which would create profound precedents and should not be
done lightly.
What does compliance mean, and is there an alternate way of meeting
the legitimate requirements?
If it is cheap the easiest way of meeting any proposed new arsenic
regulation will be to modify a new water supply so that at all times
the concentration of arsenic in all the water is below the permitted
level. But that may not be necessary for meeting any public health
goal based on chronic, as distinct from acute, effects. What is
important is that the total amount of arsenic ingested over a long
period - perhaps 5 years- be below the permitted level. For example
the water supply of a large community might use mixing and filtration
to meet the average required level. But a small water system in a
community of 1,000 to 5,000 people may have problems. They should
clearly be allowed on or more options. One might be to have supply
for drinking water separate from that used for such activities as
washing. Another might be to allow residents to use bottled water
for drinking and cooking. One could have a 2 step regulatory
system. A mandatory 50 ppb standard, and an advisory 10 ppb standard
for those water systems where there is effective participation in the
decision by all water users. The key to compliance is that all
residents in the water system be informed of the discussions on the
calculated effects on health and be able, through ordinary democratic
procedures, in the decision of what to do. At the present time I
do not find that these possibilities are discussed by Burnett and
Kahn, by the EPA, or by the vocal representative of the affected
water systems.
Costs of meeting requirements
The costs of any action to meet a regulation are far more uncertain,
and often much lower, than opponents of the regulation tend to
claim. The most well known example is the cost of reducing the
occupational exposure to vinyl chloride in the polyvinylchloride
(PVC) industry. Estimates of fixing the industry were high. The
exposures were reduced by sealing the equipment to stop fugitive
emissions. But when this was done there was a net saving of
material, and actually a saving of money! Industry tend to
estimate the cost of applying any rule tomorrow and removing arsenic
from the water tomorrow (and maybe having the equipment sent by
FEDEX!). An important feature of the proposed arsenic rule is the
date of 2006, rather than 2001, for enforcement. This allows time
for innovative approaches. For example, the Los Angeles water
district uses the Los Angeles Aqueduct which brings arsenic from Lake
Mono and Lake Crawley in the eastern Sierras. The water contains
arsenic at an average level of 23 ppb. But careful management,
filtering and mixing from different sources brings this down over the
last 10 years to less than 2 ppb in most locations. Exact costs are
not available, but they seem not to be large since the process was
done slowly. Increasingly developers in western states are
depending upon wells to supply their wtaer instead of the surface
waters that were almost universal in the past. These often contain
arsenic. But there exists an organization, the U.S. Geological
Survey that can help guide drillers where to place new wells. At a
special USGS conference in February 2001, it appears that USGS have
only recently been fully consulted. It may be that now that U.S.G.S.
have been consulted, we are likely to find out that it will be
possible to drill wells into aquifers with free of arsenic at a cost
the cost which is quite inexpensive compared to the cost or removing
arsenic from existing water supplies. These arguments suggest that
the cost of meeting the new standard will be considerably lower than
that proposed by the water industry and lower than that proposed by EPA.
Consistency with past and future regulations.
Since the arsenic lung cancer risk even at 500 ppb is approximately a
doubling of the risk that a heavy cigarette smoker has, the risk at
50 ppb, by this argument, is only a 10% increase. On the one hand
this emphasizes the magnitude of the problem cigarette smoking poses
for public health, it also suggests that arsenic at the 50 ppb level
might be considered insignificant. But this argument has never
suceeded in the public discussions of pollutant levels.
Emerson once said that excessive consistency is the hobgoblin of
small minds. Nonetheless a regulatory agency such as the E.P.A.
should have a very clear reason for any lack of consistency. These
reasons should be stated to the people. Unfortunately over the 30
years of EPA existene that has not been one of its virtues. I
will discuss a few possible implications here. If one assumes that
exposures of people to arsenic at high doses is at least as
significant as exposures of mice to thrichloroethylene, and use the
same EPA procedures, one finds that the regulatory level should be 5
ppt - an obviously unattainable goal. If even the cost-benefit
procedure used by EPA in the year 2000 for regulating arsenic had
been applied to regulation of trichloroethyelene or chromates, that
regulation would have been less severe than at present. If Burnett
and Hahn's procedures had been adopted there would have been no
regulation at all. What then do we make of the public opinions that
are implicit in the interesting movies "A Civil Action" and "Erin
Brokovich"? It seems to me that these, as representations of
public opinion, cannot be ignored. Painful though it may be to
revisit past decisions, the country is ill-served if one does not
learn from them. Of course it was not as expensive to regulate TCE as
it will be to regulate arsenic, and even less expensive to continue
to regulate TCE. Society may therefore wish to retain the existing
regulations, but that should be done after careful examination
containing the new perspective we hope that the regulators and the
public will learn from arsenic.
I noted earlier that if lives are discounted at anything approaching
the same rate as money, hazardous waste regulations and in particular
high level nuclear waste regulations must be revisited. But the
comparison of arsenic with the proposed EPA regulatory procedures for
nuclear waste in Yucca Mountain show a much more serious problem of
consistency even when no discounting is sued. We are pulling
arsenic out of the ground into the environment and forgetting about
it. Yet unlike chlorohydrocarbons which break down chemically, and
nuclear wastes which eventually decay, arsenic remains carcinogenic
for ever. The proposed Yucca mountain regulations apply only after an
unlikely malfunction. But they are sufficiently restrictive that if
they were applied to arsenic in the year 2001, most of the drinking
water, and most of the agricultural land in the U.S.A. being in
non-compliance even with no accident. This brings to the fore three
possible explanations. Either (i) the proposed Yucca mountain
regulations are excessively restrictive or (ii) the E.P.A. should
propose that arsenic above ground should be treated as a toxic waste
or (iii) the E.P.A. should come up with a clear scientific reason why
the comparison is invalid or even a modicum of consistency is
contrary to the public interest.
More information about the RadSafe
mailing list